Reuters logo
BRIEF-Basilea Pharmaceutica submits Isavuconazole European marketing authorization application
July 17, 2014 / 5:30 AM / 3 years ago

BRIEF-Basilea Pharmaceutica submits Isavuconazole European marketing authorization application

July 17 (Reuters) - Basilea Pharmaceutica AG : * Submits Isavuconazole European marketing authorization application for the

treatment of invasive mold infections * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below